GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+10.92%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$300M
AUM Growth
+$300M
(+25%)
Cap. Flow
+$49.7M
Cap. Flow
% of AUM
16.56%
Top 10 Holdings %
Top 10 Hldgs %
36%
Holding
97
New
35
Increased
14
Reduced
13
Closed
29
Top Buys
| 1 |
Biogen
BIIB
|
$12.1M |
| 2 |
Intuitive Surgical
ISRG
|
$9.69M |
| 3 |
ENDP
Endo International plc
ENDP
|
$9.56M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.04M |
| 5 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$8.07M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$11.8M |
| 2 |
Community Health Systems
CYH
|
$7.84M |
| 3 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$6.94M |
| 4 |
CELG
Celgene Corp
CELG
|
$6.92M |
| 5 |
DYAX
DYAX CORPORATION
DYAX
|
$5.86M |
Sector Composition
| 1 | Healthcare | 88.02% |
| 2 | Financials | 1.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
uniQure
QURE
$954M
| $5M | 1.62% |
+185,000
| New | +$5M |
|
|
GI
27
DELISTED
EndoChoice Holdings, Inc.
GI
| $4.91M | 1.59% |
+300,000
| New | +$4.91M |
|
28
PTC Therapeutics
PTCT
$4.41B
| $4.81M | 1.56% |
100,000
+40,000
| +67% | +$1.93M |
|
|
CLLS
29
Cellectis
CLLS
$260M
| $4.51M | 1.46% |
+125,000
| New | +$4.51M |
|
30
Vanda Pharmaceuticals
VNDA
$279M
| $4.44M | 1.44% |
+350,000
| New | +$4.44M |
|
|
ZLTQ
31
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $4.42M | 1.43% |
150,000
-75,000
| -33% | -$2.21M |
|
|
CYNA
32
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
| $4.28M | 1.39% |
+262,696
| New | +$4.28M |
|
33
Ironwood Pharmaceuticals
IRWD
$201M
| $4.22M | 1.37% |
+350,000
| New | +$4.22M |
|
|
SAGE
34
DELISTED
Sage Therapeutics
SAGE
| $4.2M | 1.36% |
57,500
-62,500
| -52% | -$4.56M |
|
|
VTAE
35
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
| $4.16M | 1.35% |
289,200
-10,800
| -4% | -$156K |
|
|
WMGI
36
DELISTED
Wright Medical Group Inc
WMGI
| $3.94M | 1.28% |
150,000
-50,000
| -25% | -$1.31M |
|
37
Arcturus Therapeutics
ARCT
$467M
| $3.92M | 1.27% |
600,000
-200,000
| -25% | -$1.31M |
|
|
VIRX
38
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $3.76M | 1.22% |
1,250,000
-500,000
| -29% | -$1.51M |
|
|
GNCA
39
DELISTED
Genocea Biosciences, Inc.
GNCA
| $3.71M | 1.2% |
270,000
-150,000
| -36% | -$2.06M |
|
40
Assembly Biosciences
ASMB
$183M
| $3.37M | 1.09% |
175,000
+50,000
| +40% | +$963K |
|
41
Elevance Health
ELV
$72.4B
| $3.28M | 1.06% |
+20,000
| New | +$3.28M |
|
42
Zevra Therapeutics
ZVRA
$501M
| $3.22M | 1.04% |
+175,000
| New | +$3.22M |
|
43
Iovance Biotherapeutics
IOVA
$800M
| $3.21M | 1.04% |
350,000
+150,000
| +75% | +$1.38M |
|
44
TherapeuticsMD
TXMD
$12.7M
| $3.14M | 1.02% |
400,000
-200,000
| -33% | -$1.57M |
|
|
SIOX
45
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $2.75M | 0.89% |
+135,000
| New | +$2.75M |
|
|
FOMX
46
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.56M | 0.83% |
+250,000
| New | +$2.56M |
|
|
BDSI
47
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.39M | 0.77% |
+300,000
| New | +$2.39M |
|
48
Puma Biotechnology
PBYI
$258M
| $2.04M | 0.66% |
17,500
-12,500
| -42% | -$1.46M |
|
49
Tonix Pharmaceuticals
TNXP
$243M
| $1.82M | 0.59% |
202,500
+202,500
| – | – |
|
|
RDUS
50
DELISTED
Radius Health, Inc.
RDUS
| $1.69M | 0.55% |
25,000
-50,000
| -67% | -$3.39M |
|